Hankosky, PhD, senior director of Cardiometabolic Health, Health Economics and Outcomes Research at Eli Lilly & Company, and corresponding author of this study, confirmed for Medical News Today that the participants were taking Mounjaro as an off-label treatment for weight management at the discretion of their prescribing physician. During their study, researchers also reported that about 32% of participants who started tirzepatide had class 3 obesity with a BMI of 40 kg/m 2 or more
Compounded versions are not FDA-approved, so if you specifically need the branded drug, bmiMD is not the right route
Liver Health and MASH There is also emerging evidence regarding the use of semaglutide for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition formerly known as NASH
If nothing else, keep a few frozen
Conversely, a review study by Hashweh et al